UK markets close in 4 hours 52 minutes

Boston Scientific Corporation (BSXC.VI)

Vienna - Vienna Delayed price. Currency in EUR
Add to watchlist
70.50-0.50 (-0.70%)
As of 09:05AM CEST. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,771,000
1,593,000
698,000
1,041,000
-82,000
-
Depreciation & amortisation
1,215,000
1,196,000
1,136,000
1,093,000
1,123,000
-
Deferred income taxes
11,000
-1,000
-63,000
-124,000
-82,000
-
Stock-based compensation
241,000
233,000
220,000
194,000
170,000
-
Change in working capital
-990,000
-770,000
-1,005,000
-351,000
-23,000
-
Accounts receivable
-266,000
-238,000
-220,000
-279,000
335,000
-
Inventory
-599,000
-660,000
-321,000
-346,000
-65,000
-
Accounts payable
-121,000
118,000
-255,000
408,000
-28,000
-
Other working capital
1,553,000
1,703,000
914,000
1,316,000
986,000
-
Other non-cash items
141,000
136,000
191,000
-25,000
202,000
-
Net cash provided by operating activities
2,477,000
2,503,000
1,526,000
1,870,000
1,508,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-924,000
-800,000
-612,000
-554,000
-522,000
-
Acquisitions, net
-1,483,000
-1,811,000
-1,542,000
-2,258,000
-3,000
-
Purchases of investments
-
-
-
-
0
-348,000
Sales/maturities of investments
-
2,000
56,000
15,000
0
-
Other investing activities
-
1,000
-
-1,000
87,000
1,000
Net cash used for investing activities
-2,375,000
-2,574,000
-2,011,000
-1,597,000
-411,000
-
Cash flows from financing activities
Debt repayment
-533,000
-4,000
-3,435,000
0
-6,843,000
-
Common stock issued
-
-
0
0
975,000
0
Common stock repurchased
-
-
0
0
-535,000
0
Dividends paid
-14,000
-28,000
-55,000
-55,000
-28,000
-
Other financing activities
-70,000
-89,000
-411,000
-100,000
-147,000
-
Net cash used provided by (used for) financing activities
1,643,000
5,000
-547,000
-95,000
294,000
-
Net change in cash
1,734,000
-70,000
-1,042,000
173,000
1,388,000
-
Cash at beginning of period
763,000
1,126,000
2,168,000
1,995,000
607,000
-
Cash at end of period
2,507,000
1,055,000
1,126,000
2,168,000
1,995,000
-
Free cash flow
Operating cash flow
2,477,000
2,503,000
1,526,000
1,870,000
1,508,000
-
Capital expenditure
-924,000
-800,000
-612,000
-554,000
-522,000
-
Free cash flow
1,553,000
1,703,000
914,000
1,316,000
986,000
-